ACM
IDYA icon

Aster Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Aster Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Buy
+3,417
New +$105K 0.03% 474
2025
Q4 		– Sell
-1,386
Closed -$37.7K – 1248
2025
Q3 		$37.7K Buy
+1,386
New +$33.5K 0.02% 556
2025
Q2 		– Sell
-3,898
Closed -$80.2K – 1290
2025
Q1 		$80.2K Buy
3,898
+3,735
+2,291% +$79.6K 0.01% 708
2024
Q4 		$4.19K Buy
+163
New +$4.62K ﹤0.01% 883

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Aster Capital Management's IDYA Position: Q2 2026 in Review

Aster Capital Management opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 3,417 shares worth $127K. The stake represents 0.03% of the portfolio and ranks #474 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in IDYA as recently as Q3 2025.

Aster Capital Management first reported a position in IDYA in Q4 2024 and has held it in 4 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Aster Capital Management held 3,417 shares of IDEAYA Biosciences worth $127K as of Q2 2026.
  • IDEAYA Biosciences was a new Aster Capital Management position in Q2 2026.
  • IDEAYA Biosciences made up 0.03% of Aster Capital Management's portfolio in Q2 2026, its #474 holding.
  • Aster Capital Management first reported a position in IDEAYA Biosciences in Q4 2024 and has held it in 4 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.